Haemorrhagic Stroke Treatment Market, Global Outlook and Forecast 2022-2028

August 2022 | 60 pages | ID: H6C0373BF75EEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Haemorrhagic Stroke Treatment in Global, including the following market information:

Global Haemorrhagic Stroke Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Haemorrhagic Stroke Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Antihypertensive Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Haemorrhagic Stroke Treatment include B. Braun, Medtronic, Bayer, Novartis, Pfizer, Merck, GlaxoSmithKline, Melsungen and Roche, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Haemorrhagic Stroke Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Haemorrhagic Stroke Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Haemorrhagic Stroke Treatment Market Segment Percentages, by Type, 2021 (%)

• Antihypertensive
• Anticoagulants
• Anticonvulsants
• Others

Global Haemorrhagic Stroke Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Haemorrhagic Stroke Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Haemorrhagic Stroke Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Haemorrhagic Stroke Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Haemorrhagic Stroke Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Haemorrhagic Stroke Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• B. Braun
• Medtronic
• Bayer
• Novartis
• Pfizer
• Merck
• GlaxoSmithKline
• Melsungen
• Roche
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Johnson & Johnson
• Daiichi Sankyo
• AstraZeneca

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Haemorrhagic Stroke Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Haemorrhagic Stroke Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HAEMORRHAGIC STROKE TREATMENT OVERALL MARKET SIZE

2.1 Global Haemorrhagic Stroke Treatment Market Size: 2021 VS 2028
2.2 Global Haemorrhagic Stroke Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Haemorrhagic Stroke Treatment Players in Global Market
3.2 Top Global Haemorrhagic Stroke Treatment Companies Ranked by Revenue
3.3 Global Haemorrhagic Stroke Treatment Revenue by Companies
3.4 Top 3 and Top 5 Haemorrhagic Stroke Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Haemorrhagic Stroke Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Haemorrhagic Stroke Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Haemorrhagic Stroke Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Haemorrhagic Stroke Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Haemorrhagic Stroke Treatment Market Size Markets, 2021 & 2028
  4.1.2 Antihypertensive
  4.1.3 Anticoagulants
  4.1.4 Anticonvulsants
  4.1.5 Others
4.2 By Type - Global Haemorrhagic Stroke Treatment Revenue & Forecasts
  4.2.1 By Type - Global Haemorrhagic Stroke Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Haemorrhagic Stroke Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Haemorrhagic Stroke Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Haemorrhagic Stroke Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Haemorrhagic Stroke Treatment Revenue & Forecasts
  5.2.1 By Application - Global Haemorrhagic Stroke Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Haemorrhagic Stroke Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Haemorrhagic Stroke Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Haemorrhagic Stroke Treatment Market Size, 2021 & 2028
6.2 By Region - Global Haemorrhagic Stroke Treatment Revenue & Forecasts
  6.2.1 By Region - Global Haemorrhagic Stroke Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Haemorrhagic Stroke Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Haemorrhagic Stroke Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Haemorrhagic Stroke Treatment Revenue, 2017-2028
  6.3.2 US Haemorrhagic Stroke Treatment Market Size, 2017-2028
  6.3.3 Canada Haemorrhagic Stroke Treatment Market Size, 2017-2028
  6.3.4 Mexico Haemorrhagic Stroke Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Haemorrhagic Stroke Treatment Revenue, 2017-2028
  6.4.2 Germany Haemorrhagic Stroke Treatment Market Size, 2017-2028
  6.4.3 France Haemorrhagic Stroke Treatment Market Size, 2017-2028
  6.4.4 U.K. Haemorrhagic Stroke Treatment Market Size, 2017-2028
  6.4.5 Italy Haemorrhagic Stroke Treatment Market Size, 2017-2028
  6.4.6 Russia Haemorrhagic Stroke Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Haemorrhagic Stroke Treatment Market Size, 2017-2028
  6.4.8 Benelux Haemorrhagic Stroke Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Haemorrhagic Stroke Treatment Revenue, 2017-2028
  6.5.2 China Haemorrhagic Stroke Treatment Market Size, 2017-2028
  6.5.3 Japan Haemorrhagic Stroke Treatment Market Size, 2017-2028
  6.5.4 South Korea Haemorrhagic Stroke Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Haemorrhagic Stroke Treatment Market Size, 2017-2028
  6.5.6 India Haemorrhagic Stroke Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Haemorrhagic Stroke Treatment Revenue, 2017-2028
  6.6.2 Brazil Haemorrhagic Stroke Treatment Market Size, 2017-2028
  6.6.3 Argentina Haemorrhagic Stroke Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Haemorrhagic Stroke Treatment Revenue, 2017-2028
  6.7.2 Turkey Haemorrhagic Stroke Treatment Market Size, 2017-2028
  6.7.3 Israel Haemorrhagic Stroke Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Haemorrhagic Stroke Treatment Market Size, 2017-2028
  6.7.5 UAE Haemorrhagic Stroke Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 B. Braun
  7.1.1 B. Braun Corporate Summary
  7.1.2 B. Braun Business Overview
  7.1.3 B. Braun Haemorrhagic Stroke Treatment Major Product Offerings
  7.1.4 B. Braun Haemorrhagic Stroke Treatment Revenue in Global Market (2017-2022)
  7.1.5 B. Braun Key News
7.2 Medtronic
  7.2.1 Medtronic Corporate Summary
  7.2.2 Medtronic Business Overview
  7.2.3 Medtronic Haemorrhagic Stroke Treatment Major Product Offerings
  7.2.4 Medtronic Haemorrhagic Stroke Treatment Revenue in Global Market (2017-2022)
  7.2.5 Medtronic Key News
7.3 Bayer
  7.3.1 Bayer Corporate Summary
  7.3.2 Bayer Business Overview
  7.3.3 Bayer Haemorrhagic Stroke Treatment Major Product Offerings
  7.3.4 Bayer Haemorrhagic Stroke Treatment Revenue in Global Market (2017-2022)
  7.3.5 Bayer Key News
7.4 Novartis
  7.4.1 Novartis Corporate Summary
  7.4.2 Novartis Business Overview
  7.4.3 Novartis Haemorrhagic Stroke Treatment Major Product Offerings
  7.4.4 Novartis Haemorrhagic Stroke Treatment Revenue in Global Market (2017-2022)
  7.4.5 Novartis Key News
7.5 Pfizer
  7.5.1 Pfizer Corporate Summary
  7.5.2 Pfizer Business Overview
  7.5.3 Pfizer Haemorrhagic Stroke Treatment Major Product Offerings
  7.5.4 Pfizer Haemorrhagic Stroke Treatment Revenue in Global Market (2017-2022)
  7.5.5 Pfizer Key News
7.6 Merck
  7.6.1 Merck Corporate Summary
  7.6.2 Merck Business Overview
  7.6.3 Merck Haemorrhagic Stroke Treatment Major Product Offerings
  7.6.4 Merck Haemorrhagic Stroke Treatment Revenue in Global Market (2017-2022)
  7.6.5 Merck Key News
7.7 GlaxoSmithKline
  7.7.1 GlaxoSmithKline Corporate Summary
  7.7.2 GlaxoSmithKline Business Overview
  7.7.3 GlaxoSmithKline Haemorrhagic Stroke Treatment Major Product Offerings
  7.7.4 GlaxoSmithKline Haemorrhagic Stroke Treatment Revenue in Global Market (2017-2022)
  7.7.5 GlaxoSmithKline Key News
7.8 Melsungen
  7.8.1 Melsungen Corporate Summary
  7.8.2 Melsungen Business Overview
  7.8.3 Melsungen Haemorrhagic Stroke Treatment Major Product Offerings
  7.8.4 Melsungen Haemorrhagic Stroke Treatment Revenue in Global Market (2017-2022)
  7.8.5 Melsungen Key News
7.9 Roche
  7.9.1 Roche Corporate Summary
  7.9.2 Roche Business Overview
  7.9.3 Roche Haemorrhagic Stroke Treatment Major Product Offerings
  7.9.4 Roche Haemorrhagic Stroke Treatment Revenue in Global Market (2017-2022)
  7.9.5 Roche Key News
7.10 Boehringer Ingelheim
  7.10.1 Boehringer Ingelheim Corporate Summary
  7.10.2 Boehringer Ingelheim Business Overview
  7.10.3 Boehringer Ingelheim Haemorrhagic Stroke Treatment Major Product Offerings
  7.10.4 Boehringer Ingelheim Haemorrhagic Stroke Treatment Revenue in Global Market (2017-2022)
  7.10.5 Boehringer Ingelheim Key News
7.11 Bristol-Myers Squibb
  7.11.1 Bristol-Myers Squibb Corporate Summary
  7.11.2 Bristol-Myers Squibb Business Overview
  7.11.3 Bristol-Myers Squibb Haemorrhagic Stroke Treatment Major Product Offerings
  7.11.4 Bristol-Myers Squibb Haemorrhagic Stroke Treatment Revenue in Global Market (2017-2022)
  7.11.5 Bristol-Myers Squibb Key News
7.12 Johnson & Johnson
  7.12.1 Johnson & Johnson Corporate Summary
  7.12.2 Johnson & Johnson Business Overview
  7.12.3 Johnson & Johnson Haemorrhagic Stroke Treatment Major Product Offerings
  7.12.4 Johnson & Johnson Haemorrhagic Stroke Treatment Revenue in Global Market (2017-2022)
  7.12.5 Johnson & Johnson Key News
7.13 Daiichi Sankyo
  7.13.1 Daiichi Sankyo Corporate Summary
  7.13.2 Daiichi Sankyo Business Overview
  7.13.3 Daiichi Sankyo Haemorrhagic Stroke Treatment Major Product Offerings
  7.13.4 Daiichi Sankyo Haemorrhagic Stroke Treatment Revenue in Global Market (2017-2022)
  7.13.5 Daiichi Sankyo Key News
7.14 AstraZeneca
  7.14.1 AstraZeneca Corporate Summary
  7.14.2 AstraZeneca Business Overview
  7.14.3 AstraZeneca Haemorrhagic Stroke Treatment Major Product Offerings
  7.14.4 AstraZeneca Haemorrhagic Stroke Treatment Revenue in Global Market (2017-2022)
  7.14.5 AstraZeneca Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Haemorrhagic Stroke Treatment Market Opportunities & Trends in Global Market
Table 2. Haemorrhagic Stroke Treatment Market Drivers in Global Market
Table 3. Haemorrhagic Stroke Treatment Market Restraints in Global Market
Table 4. Key Players of Haemorrhagic Stroke Treatment in Global Market
Table 5. Top Haemorrhagic Stroke Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Haemorrhagic Stroke Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Haemorrhagic Stroke Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Haemorrhagic Stroke Treatment Product Type
Table 9. List of Global Tier 1 Haemorrhagic Stroke Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Haemorrhagic Stroke Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Haemorrhagic Stroke Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Haemorrhagic Stroke Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Haemorrhagic Stroke Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Haemorrhagic Stroke Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Haemorrhagic Stroke Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Haemorrhagic Stroke Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2023-2028
Table 30. B. Braun Corporate Summary
Table 31. B. Braun Haemorrhagic Stroke Treatment Product Offerings
Table 32. B. Braun Haemorrhagic Stroke Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Medtronic Corporate Summary
Table 34. Medtronic Haemorrhagic Stroke Treatment Product Offerings
Table 35. Medtronic Haemorrhagic Stroke Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Bayer Corporate Summary
Table 37. Bayer Haemorrhagic Stroke Treatment Product Offerings
Table 38. Bayer Haemorrhagic Stroke Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Novartis Corporate Summary
Table 40. Novartis Haemorrhagic Stroke Treatment Product Offerings
Table 41. Novartis Haemorrhagic Stroke Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Haemorrhagic Stroke Treatment Product Offerings
Table 44. Pfizer Haemorrhagic Stroke Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Merck Corporate Summary
Table 46. Merck Haemorrhagic Stroke Treatment Product Offerings
Table 47. Merck Haemorrhagic Stroke Treatment Revenue (US$, Mn), (2017-2022)
Table 48. GlaxoSmithKline Corporate Summary
Table 49. GlaxoSmithKline Haemorrhagic Stroke Treatment Product Offerings
Table 50. GlaxoSmithKline Haemorrhagic Stroke Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Melsungen Corporate Summary
Table 52. Melsungen Haemorrhagic Stroke Treatment Product Offerings
Table 53. Melsungen Haemorrhagic Stroke Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Roche Corporate Summary
Table 55. Roche Haemorrhagic Stroke Treatment Product Offerings
Table 56. Roche Haemorrhagic Stroke Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Boehringer Ingelheim Corporate Summary
Table 58. Boehringer Ingelheim Haemorrhagic Stroke Treatment Product Offerings
Table 59. Boehringer Ingelheim Haemorrhagic Stroke Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Bristol-Myers Squibb Corporate Summary
Table 61. Bristol-Myers Squibb Haemorrhagic Stroke Treatment Product Offerings
Table 62. Bristol-Myers Squibb Haemorrhagic Stroke Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Johnson & Johnson Corporate Summary
Table 64. Johnson & Johnson Haemorrhagic Stroke Treatment Product Offerings
Table 65. Johnson & Johnson Haemorrhagic Stroke Treatment Revenue (US$, Mn), (2017-2022)
Table 66. Daiichi Sankyo Corporate Summary
Table 67. Daiichi Sankyo Haemorrhagic Stroke Treatment Product Offerings
Table 68. Daiichi Sankyo Haemorrhagic Stroke Treatment Revenue (US$, Mn), (2017-2022)
Table 69. AstraZeneca Corporate Summary
Table 70. AstraZeneca Haemorrhagic Stroke Treatment Product Offerings
Table 71. AstraZeneca Haemorrhagic Stroke Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Haemorrhagic Stroke Treatment Segment by Type in 2021
Figure 2. Haemorrhagic Stroke Treatment Segment by Application in 2021
Figure 3. Global Haemorrhagic Stroke Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Haemorrhagic Stroke Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Haemorrhagic Stroke Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Haemorrhagic Stroke Treatment Revenue in 2021
Figure 8. By Type - Global Haemorrhagic Stroke Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Haemorrhagic Stroke Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Haemorrhagic Stroke Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Haemorrhagic Stroke Treatment Revenue Market Share, 2017-2028
Figure 12. US Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Haemorrhagic Stroke Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Haemorrhagic Stroke Treatment Revenue Market Share, 2017-2028
Figure 24. China Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Haemorrhagic Stroke Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Haemorrhagic Stroke Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Haemorrhagic Stroke Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. B. Braun Haemorrhagic Stroke Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Medtronic Haemorrhagic Stroke Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bayer Haemorrhagic Stroke Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis Haemorrhagic Stroke Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Haemorrhagic Stroke Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Merck Haemorrhagic Stroke Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. GlaxoSmithKline Haemorrhagic Stroke Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Melsungen Haemorrhagic Stroke Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Roche Haemorrhagic Stroke Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Boehringer Ingelheim Haemorrhagic Stroke Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Bristol-Myers Squibb Haemorrhagic Stroke Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Johnson & Johnson Haemorrhagic Stroke Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Daiichi Sankyo Haemorrhagic Stroke Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. AstraZeneca Haemorrhagic Stroke Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)